Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 21, 2025 | McElvaine Value Fund | - | -4.0% | AIM CN, CFP CN, EXCE, FIH/U CN, GUD CN, HHH, JAR LN, MDOB LN, MXG CN, ONEX CN, PSK CN | contrarian, insider ownership, low leverage, tangible assets, value | The letter emphasizes contrarian value investing focused on unpopular, asset-rich companies with insider alignment and low leverage. Management is skeptical of speculative enthusiasm around AI-related investments and prefers tangible assets and discounted cash flows. Patience is highlighted as essential as intrinsic value realization lags market sentiment. | GUD CN MPX CN AIM CN ONEX CN CFP CN HHH FIH CN PSK CN |
View |
| 2021 Q2 | Jun 30, 2021 | McElvaine Value Fund | - | -28.2% | GUD CN, JEF, MXG CN, TOU CN | - | View | ||
| 2020 Q2 | Jun 30, 2020 | McElvaine Value Fund | - | -15.6% | GUD CN, JEF, MXG CN, TOU CN | - | View | ||
| 2024 Q4 | Dec 31, 2024 | McElvaine Value Fund | - | 19.2% | 2728 HK, CFP CN, EXCE, FIH/U CN, GUD CN, MXG CN, ONEX CN, PSK CN, SEG MM | - | View | ||
| 2021 Q4 | Dec 31, 2021 | McElvaine Value Fund | - | 40.6% | 2728 HK, GUD CN, JEF, MXG CN, TOU CN | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Fund Letters | Tim McElvaine | Knight Therapeutics Inc. | Health Care | Pharmaceuticals | Bull | Toronto Stock Exchange | acquisition, cashflow, growth, LatAm, pharma | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||